Tag: Liver
Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
1990 to 2017 Saw Increases in Primary Liver Cancer Cases
PLC cases diagnosed before age 30 decreased, but those diagnosed at 30 to 59, ≥60 years increased
Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
Risk for 10-year liver-related mortality also lower among aspirin users with chronic hepatitis B or C
QoL Extended With Atezolizumab + Bevacizumab in Liver Cancer
And, triplet and doublet drug regimens delay decline in quality of life in BRAF V600E metastatic CRC
Patients With Cirrhosis Have Considerable Financial Burden
Lack of insurance, financial distress resulting in delayed medical care tied to lower odds of HCC surveillance
Lipophilic Statins May Cut Liver Cancer in Chronic Viral Hepatitis
Inverse link is dose-dependent; lowest 10-year HCC risk seen with 600 or more lipophilic statin cDDDs
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer
Findings seen for patients receiving direct-acting antivirals with complete response to liver cancer treatment
Aspirin May Improve Liver Function After Embolization of HCC
Study suggests aspirin is hepatoprotective, improves survival by reducing liver inflammation
Percutaneous Ablation in Liver Cancer Tied to Better Outcomes
Intervention linked to better short-term outcomes versus surgical procedures
Conception by IVF May Increase Risk for Rare Childhood Cancer
Rate of hepatic tumors higher among children conceived via IVF
